FeesSafety
Pluang+

Everpure raises 2027 revenue and profit forecasts for third quarter in a row, Wedbush keeps 'outperform' rating.

Company Fundamentals
20 Nov 2026, 02:13 WIB
Proactive Investors
View Source
Bullish
Everpure raises 2027 revenue and profit forecasts for third quarter in a row, Wedbush keeps 'outperform' rating.

Everpure has increased its full-year 2027 revenue and operating profit forecasts for the third consecutive quarter, driven by strong demand that exceeded expectations. Third-quarter revenue rose 51% year-on-year to $1.46 billion, surpassing guidance by about $125 million, with non-GAAP earnings per share at $0.86 beating estimates. Management raised the full-year revenue forecast to $5.20-$5.21 billion and operating profit to $1.08-$1.09 billion. Wedbush reiterated its 'outperform' rating and $130 price target, citing conservative fourth-quarter guidance and potential upside from hyperscale sales and market-share gains due to strategic price reductions.

Everpure's third-quarter revenue rose 51% year-on-year to $1.46 billion, surpassing guidance by about $125 million as of November 20, 2026. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 20, 2026 06:11 WIB: out of 150 priced US tech stocks, 13 rose and 137 fell. Notable movers include AMD at USD 475.50 with a 1-day change of -10.31%, Zoom Video Communications at USD 83.50 down 9.91%, and Veritone Inc at USD 0.38 up 9.32%, with typical hold times ranging from 18 to 94 days and varied Pluang order activity percentages.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App